THE LONG-AWAITED FULL-LENGTH RETURN OF THE US DEATH METAL PIONEERS FOR A NEW BOUT OF SUPREME SICKNESS.
“Absolutely brilliant. “Morbidity Triumphant” is definitely one of the year’s best death metal albums” – Blabbermouth
Since first bursting onto the death metal scene with the now genre classic ‘Severed Survival’ back in 1989, and following up with the equally revered ‘Mental Funeral’ album, the influential US quartet has carved an unwavering legacy over three decades as masters and purveyors of the vile sides of the extreme metal spectrum. And now, Autopsy marks its reinvigorated return, presenting the first new full-length studio opus since 2014’s ‘Tourniquets, Hacksaws and Graves’ with ‘Morbidity Triumphant’; a savage offering of brutal death, showing the US legends still have an unbridled hunger for the sadistic, never reluctant to step beyond the threshold of decency.
‘Morbidity Triumphant’, the band’s eighth album, is truly a dark delight for seasoned and new listeners alike, with a raw organic sound perfectly encapsulating what makes Autopsy so distinguishable among its peers, for what could easily be considered one of its strongest offerings to date.
The driving force of Autopsy as ever is the virtuoso guitar pairing of Eric Cutler and Danny Coralles, effortlessly trading off their schizophrenic leads and switching from all-out death metal madness to groove-laden heavy doom, with unmistakable drum/vocal legend Chris Reifert being master of proceedings, spewing his own infinitely creative maniacal musings. ‘Morbidity Triumphant’ also notably marks the first album to feature new bassist Greg Wilkinson, currently also seen in Static Abyss along with Chris.
‘Morbidity Triumphant’ was recorded at Opus Studios, with long-associated engineer Adam Munoz at the helm. Mastering was completed by Ken Lee.
The cover artwork appears courtesy of Wes Benscoter (Slayer, Bloodbath), with a new work of twisted and sinister genius.
Autopsy will be supporting ‘Morbidity Triumphant’ with a series of dates throughout the remainder of 2022.